
Biosearch Technologies is part of LGC Diagnostics & Genomics – Learn More
Genotyping by sequencing (GBS), also known as Sequence-based genotyping (SBG), has become the method of choice for high throughput discovery of SNPs and simultaneous genotyping in multiple DNA samples. It combines restriction enzyme-mediated complexity reduction with the high-throughput sequencing capacity of Illumina platforms to score random markers across an entire genome
LGC Biosearch Technologies sample preparation and sequencing experts provide unrivalled support and assist in ensuring the optimal protocol is selected for your application. With expertise in techniques ranging from normalised GBS (nGBS), double digest RadSeq (ddRAD) and other GBS or targeted sequencing-based approaches.
Biosearch Technologies has secured a license for the commercial offering and use of GBS (sometimes known as SBG) technology across all species and geographies from KeyGene.
Want to learn more about our
targeted GBS offerings? Click here.
Applications for genotyping by sequencing include:
For bespoke technical advice on GBS and sequencing-based technologies from Biosearch Technologies, please contact via the form below.
Keygene N.V. owns patents and patent applications protecting its sequence based genotyping technologies, as described by Truong et al., PLoS ONE 7: e37565, 2012 . LGC Biosearch Technologies has a licence from KeyGene N.V. to offer the GBS service for any organisms provided that use and application in human and animal shall be limited to research use only.
| Europe, Middle East, and Africa | |
|---|---|
| UK | +44 1992 470 757 |
| Germany | +49 30 1663 54600 |
| North America, Latin America | |
| Wisconsin, USA | +1 888 575 9695 |
| Asia Pacific | |
| China | +8621-22509000 |
| Singapore | +65 6734 4800 |